{"id":4010,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:37:55","modified_gmt":"2026-02-17T10:37:55","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/sv\/andromedic-esho-2014\/","title":{"rendered":"Andromedic intervention ESHO 2014"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/sv\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/sv\/andromedic-esho-2014\/\",\n      \"name\": \"Kliniska pr\u00f6vningar med Andromedic HyDeep 600 WM - ESHO-kongressen\",\n      \"description\": \"Data fr\u00e5n kliniska studier med HyDeep 600 WM f\u00f6r livmoderhalscancer och multicenter genomf\u00f6rbarhetsstudier presenterade vid ESHO-kongressen.\",\n      \"inLanguage\": \"sv-SE\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"LACC-studie om livmoderhalscancer\",\n          \"description\": \"Studie p\u00e5 8 patienter som visar 100 % lokal kontroll vid anv\u00e4ndning av HyDeep 600 WM och HDR-brakyterapi.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Livmoderhalscancer\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Spansk fall-kontrollstudie\",\n          \"description\": \"Omfattande genomf\u00f6rbarhetsstudie (feasibility study) med 293 patienter f\u00f6rdelade p\u00e5 9 tum\u00f6rlokalisationer.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Avancerat onkologiskt hypertermisystem \/ professionell utrustning f\u00f6r modulerad RF-hypertermi (13,56 MHz) f\u00f6r lokal djup hypertermi.\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/sv\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Pris p\u00e5 beg\u00e4ran\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Ledande teknologi f\u00f6r djup hypertermi med kliniskt validerade protokoll.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">European Society for Hyperthermic Oncology: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Andromedic-intervention \u2013 Dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">Under <a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a> tillk\u00e4nnagav <a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\"><strong>Dr. Salvatore Conte<\/strong><\/a> en stor milstolpe f\u00f6r Andromedics hypertermi-team: framg\u00e5ngsrik produktion och leverans av 25 <a href=\"https:\/\/andromedichyperthermia.com\/andromedic-hydeep-600wm-deep-local-hyperthermia-device-2\/\"><strong>HyDeep 600WM<\/strong>-enheter f\u00f6r djup lokal hypertermi<\/a> p\u00e5 endast 18 m\u00e5nader, med ytterligare 40 enheter \u00f6ronm\u00e4rkta f\u00f6r den indiska marknaden.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase;\">Presenterade kliniska studier: HyDeep 600WM avancerad onkologisk hypertermi<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Kemostr\u00e5lbehandling + hypertermi + HDR-brachyterapi f\u00f6r LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>M\u00c5L:<\/strong> Att unders\u00f6ka resultatet av att kombinera veckovis cisplatin och djup lokal hypertermi med IMRT f\u00f6ljt av BRT f\u00f6r lokalt avancerad livmoderhalscancer (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MATERIAL OCH METODER:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n\u00a0\t<\/p>\n<li><strong>Patientgrupp:<\/strong> 8 patienter (3 stadium IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Protokoll:<\/strong> 50,4 Gy till b\u00e4ckenlymfk\u00f6rtlar med SIB till GTV (61,8 Gy totalt) i 28 fraktioner. BRT-dos: 21 Gy i 3 fraktioner.<\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Samtidig terapi:<\/strong> Veckovis Cisplatin 40mg\/m\u00b2 + HT en g\u00e5ng i veckan.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">RESULTAT OCH SLUTSATSER:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">100 % LOKAL KONTROLL UPPN\u00c5DDES. Ingen behandlingsrelaterad akut eller sen grad 3 till 4-toxicitet observerades.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">&#8221;Till\u00e4gg av djup lokal hypertermi till kemostr\u00e5lbehandling representerar en lovande ny strategi med utm\u00e4rkt tolerans.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Genomf\u00f6rbarhetsstudie (case-control) \u2013 djup lokal hypertermi &#8211; Andalusien, Spanien<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>Introduktion:<\/strong> Den f\u00f6rsta kliniska pr\u00f6vningen i Spanien som kombinerar djup lokal hypertermi med standardbehandlingar f\u00f6r cancer inom det offentliga h\u00e4lsov\u00e5rdssystemet.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Studiedesign:<\/strong> Prospektiv case-control-studie. 293 patienter totalt (97 i aktiv fas vs. 196 kontroller). 9 tum\u00f6rlokalisationer.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Behandlingsparametrar:<\/strong> 10 sessioner (2-3\/vecka), 1 timmes varaktighet, 150W\u2013400W med anv\u00e4ndning av <strong>HyDeep 600WM-enhet f\u00f6r modulerad hypertermi<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">Prelimin\u00e4ra data (undergrupp p\u00e5 22 patienter):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n\u00a0\t<\/p>\n<li><strong>Glioblastom (2c)<\/strong><\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Huvud och hals (7c)<\/strong><\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Preoperativ rektum (3c)<\/strong><\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Br\u00f6stcancer (3c)<\/strong><\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Lunga (NSCLC &#8211; 11c)<\/strong><\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Prostata (4c)<\/strong><\/li>\n<p>\u00a0\t<\/p>\n<li><strong>Cervix och metastaser<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81.2%<\/span><br \/>\n<strong>H\u00d6G TOLERANS<\/strong><br \/>\n<small>Patienter n\u00f6jda eller mycket n\u00f6jda<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66.6%<\/span><br \/>\n<strong>NOLL TOXICITET<\/strong><br \/>\n<small>Inga biverkningar rapporterade<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>SLUTSATS:<\/strong> Djup lokal hypertermi \u00e4r genomf\u00f6rbar i rutinm\u00e4ssig offentlig sjukhusv\u00e5rd utan extraordin\u00e4ra resurser. R\u00e4tt patienturval s\u00e4kerst\u00e4ller minimal (grad 1) toxicitet.<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Ladda ner fullst\u00e4ndigt studieprotokoll (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">ESHO vetenskapliga postrar och dokumentation<\/h3>\n<div id='gallery-1' class='gallery galleryid-4010 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/sv\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1343\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1343'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/sv\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1322\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1322'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/sv\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1301\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1301'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>European Society for Hyperthermic Oncology: ESHO 2014 Andromedic-intervention \u2013 Dr. Salvatore Conte Under ESHO 2014 tillk\u00e4nnagav Dr. Salvatore Conte en stor milstolpe f\u00f6r Andromedics hypertermi-team: framg\u00e5ngsrik produktion och leverans av 25 HyDeep 600WM-enheter f\u00f6r djup lokal hypertermi p\u00e5 endast 18 m\u00e5nader, med ytterligare 40 enheter \u00f6ronm\u00e4rkta f\u00f6r den indiska marknaden. Presenterade kliniska studier: HyDeep 600WM&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17354,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-4010","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/pages\/4010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/comments?post=4010"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/pages\/4010\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/media\/17354"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/media?parent=4010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}